Instil Bio Stock (NASDAQ: TIL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 27.000 / 18.505K |
Day Range | - - - |
52 Wk Range | 6.070 - 14.000 |
Market Cap | $69.852M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 0.28% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Instil Bio (NASDAQ: TIL) through any online brokerage.
Other companies in Instil Bio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Connect Biopharma Hldgs (NASDAQ:CNTB) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for Instil Bio (NASDAQ: TIL) was reported by Jefferies on Friday, April 12, 2024. The analyst firm set a price target for 11.00 expecting TIL to rise to within 12 months (a possible 2.42% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Instil Bio (NASDAQ: TIL) is $10.74 last updated April 12, 2024 at 8:51 AM EDT.
There are no upcoming dividends for Instil Bio.
Instil Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Instil Bio.
Instil Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.